Novo Nordisk settles Minnesota insulin pricing case

Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35
Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable prices that led several diabetics to ration their medications with fatal consequences.
Novo Nordisk settles Minnesota insulin pricing case: report
Novo Nordisk (NVO) has reportedly settled a lawsuit filed by the state of Minnesota over the pricing of its insulin products by agreeing to cap costs at $35 per month. Under the settlement ...
Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi
Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes drug.
Novo Nordisk insulin now $35 per month for Minnesotans thanks to Attorney General Keith Ellison
Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for $35 per month.
Minnesota AG announces Novo Nordisk settlement over insulin costs
Minnesota Attorney General Keith Ellison says his office has reached a settlement with Novo Nordisk over high insulin costs.
Novo Nordisk to cap insulin prices in Minnesota settlement
Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes drug.
Latest pharma lawsuit settlement expands low-cost insulin to more Minnesotans
Minnesota announced a third and final settlement Monday in its price-fixing lawsuit against the so-called Big Three manufacturers of insulin, expanding low-cost access to the diabetes drug. Novo Nordisk agreed to cap insulin prices for the next five years so that Minnesotans won’t have to pay any more than $35 for monthly prescriptions.
Minnesota settles lawsuit with insulin provider Norvo Nordisk which will keep prices capped at $35 a month
Minnesota Attorney General Keith Ellison announced a settlement with pharmaceutical company Norvo Nordisk over allegations of inflated insulin prices. The suit was filed in 2018, and in that time Ellison says insulin costs had reached $6,
Minnesota insulin cost lawsuit settlement caps price
The settlement means all Minnesotans can purchase insulin from the three biggest insulin manufacturers for just $35 per month.
Valley News Live3d
Attorney General secures $35 Novo Nordisk insulin for Minnesotans
The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin ... (3 vials or 2 packs of pens) for customers paying with cash.
Star Tribune3d
Minnesota reaches Novo Nordisk settlement, locks in insulin at $35 per month
In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...
pharmaphorum2y
Novo Nordisk launches first smart insulin pens for NHS patients
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the ...
Yahoo Finance1mon
Novo Nordisk A/S (NVO): A Bull Case Theory
Novo Nordisk’s Phase 3 REDEFINE 1 study results for CagriSema have sparked a mixed reaction, with the drug achieving a 22.7% weight loss at 68 weeks, slightly edging out Lilly’s Zepbound at 22.5%.